Arcutis Biotherapeutics

Omeros

Annexon, Inc

uniQure

Tango Therapeutics

Zymeworks Inc

Prothena

Viridian Therapeutics

Praxis Precision Medicines

Apogee Therapeutics Inc.

Virtus LifeSci Biotech Clinical Trials ETF

BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials.

Loncar Cancer Immunotherapy ETF

Proshares S&P Kensho Cleantech ETF

iShares U.S. Home Construction ETF

Invesco WilderHill Clean Energy ETF

Wall Street was moderately upbeat last week with the S&P 500, the Dow Jones and the Nasdaq gaining 0.87%, 1.6% and 0.3%, respectively. However, the small-cap index – the Russell 2000 – has advanced 6% as consumer inflation print came in at cooler-than-expected.

5 Top ETFs of Last Week

iShares Micro-Cap ETF

SPDR S&P Regional Banking ETF

June inflation data has deepened the market's confidence that the Fed would begin cutting interest rates in September, leading to a sector rotation from the hot technology sector to the laggards that could benefit from falling rates like industrials and small caps.

Inflation Cools in June, Triggers Spike in Laggard ETFs

Breakwave Dry Bulk Shipping ETF

First Trust SkyBridge Crypto Industry and Digital Economy ETF

Simplify Tail Risk Strategy ETF

Proshares Ether Strategy Etf

Amplify Junior Silver Miners ETF

United States Natural Gas Fund LP

Sprott Junior Uranium Miners ETF

Invesco DB US Dollar Index Bullish Fund

Themes Generative Artificial Intelligence ETF

Wall Street surged to close out February with the S&P 500 and Nasdaq Composite notching their best February since 2015.

Top & Flop ETF Areas of Wall Street's Best February in Decade

Sonicshares Global Shipping ETF

Sprott Lithium Miners ETF

Invesco Dynamic Oil & Gas Services ETF

Global X Solar ETF

Global X Defense Tech ETF

Roundhill Cannabis ETF

The third-quarter was an average-to-downbeat period for investors, mainly due to rising rates.

Top and Flop Industry ETFs of Q3

ALPS Medical Breakthroughs ETF

Global X MSCI Nigeria ETF

Aberdeen Standard Physical Palladium Shares ETF 

iPath Series B Bloomberg Platinum Subindex Total Return ETN

GraniteShares Platinum Trust

Aberdeen Standard Physical Platinum Shares ETF

Invesco DWA Healthcare Momentum ETF

Simplify Propel Opportunities ETF

In a somewhat surprising turn, biotech and life sciences-focused ETFs were the driving themes in the last week's top-performing ETFs, with the ALPS Medical Breakthroughs ETF (SBIO) leading the way with a 10% return.

ALPS' Biotech ETF SBIO Week's Top Performer

VanEck Vectors Biotech ETF

First Trust NYSE Arca Biotechnology Index Fund

iShares Nasdaq Biotechnology ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare Providers ETF

iShares U.S. Medical Devices ETF

iShares U.S. Healthcare ETF

Invesco Dynamic Biotechnology & Genome ETF

Invesco Dynamic Pharmaceuticals ETF

VanEck Vectors Pharmaceutical ETF

Invesco S&P 500 Equal Weight Health Care ETF

Vanguard Health Care ETF

SPDR S&P Biotech ETF

Health Care Select Sector SPDR Fund

SPDR S&P Pharmaceuticals ETF

How SVB's collapse is impacting healthcare startups. Pfizer to buy Seagen for $43B.

The Fall Of SVB: What It Means For Healthcare Startups

Global X Blockchain ETF

Wall Street has been witnessing the biggest banking meltdown since 2008. These ETF investing areas are at tight spots.

3 ETF Areas Likely to be in Tight Spots Post Banking Crisis

Global X Longevity Thematic ETF 

ARK Genomic Revolution Multi-Sector ETF

Virtus LifeSci Biotech Products ETF

BlackRock Future Health ETF

Principal Healthcare Innovators Index ETF

Global X Telemedicine & Digital Health ETF

Fidelity MSCI Health Care ETF

First Trust Nasdaq Pharmaceuticals ETF 

First Trust Health Care AlphaDEX Fund

Amplify Treatments Testing & Advancements ETF

Global X Genomics & Biotechnology ETF

 Franklin Genomic Advancements ETF

ROBO Global Healthcare Technology and Innovation ETF

Invesco Nasdaq Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

iShares Global Healthcare ETF

Eli Lilly

Global X Longevity Thematic ETF

First Trust Indxx Medical Devices ETF

Merck

Novo Nordisk

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Simplify Health Care ETF

Invesco S&P SmallCap Health Care ETF

Wisdomtree BioRevolution Fund

SPDR S&P Health Care Equipment ETF

SPDR S&P Health Care Services ETF

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

Can Health Care Stocks Outperform Again In 2023?

ALPS Clean Energy ETF

iShares Blockchain And Tech ETF

Sprott Uranium Miners ETF

Strategic Crispr & Gene Editing Technology ETF

Though Wall Street delivered a subdued performance in Q3, these sector ETFs offered double-digit returns.

What Slump? 4 Sector ETFs Up At Least 14% in Q3

iShares Neuroscience And Healthcare ETF

Sprott Gold Miners ETF

Global X Silver Miners ETF

SoFi Web 3 ETF

Wall Street was downbeat last week led by Apple after it dropped plans to boost production of its new iPhones.

4 Best ETF Areas of Last Week That Are Up At Least 5%

iShares MSCI Brazil Small-Cap ETF

Global X MLP ETF

UBS ETRACS Alerian MLP Infrastructure Index ETN Series B

First Trust NASDAQ Clean Edge Green Energy Index Fund

iShares MSCI India Small Cap ETF

Global X Uranium ETF

These ETF areas won in the third quarter of 2022.

5 Best Areas of Q3 of 2022 & Their Top ETFs

The recently enacted Inflation Reduction Act looks to rein in prescription drug prices and could impact the pharma industry's long-term financial performance. The legislation caps out-of-pocket costs for Medicare prescriptions at $2,000 per year, starting in 2025.

What The Inflation Reduction Act Means For Drug Prices

Pfizer

The biotech corner of the broad healthcare sector outperformed last week on speculation over a takeover bid for Global Blood Therapeutics.

Biotech Wins Last Week: 5 Best ETFs

iShares North American Tech-Multimedia Networking ETF

Invesco DWA Technology Momentum ETF

Invesco Solar ETF

SPDR S&P Homebuilders ETF

Wall Street logged the best month since November 2020 in July. These are the winning ETFs.

Stocks' Best Month Since 2020: Top ETF Areas of July

These ETFs have braved the inflationary fears in the past three months and topped the S&P 500.

3 ETFs Braving Inflationary Fears in Past Three Months

Biotech, the downtrodden segment of the market, has made a solid comeback on bargain hunting.

5 ETFs Riding High on the Biotech Comeback

iShares Evolved U.S. Innovative Healthcare ETF

Pharma and biotech ETFs are in great shape and are trading at a one-month high level.

Pharma & Biotech ETFs at One-Month High: Here's Why

Biotechnology stocks and sector-related exchange traded funds have been gaining momentum as investors return to this downtrodden segment of the market. Over the past month, the Virtus LifeSci Biotech Clinical Trials ETF (BBC) gained 15.5%, the Virtus LifeSci Biotech Products ETF (BBP) rose 12.8%, the SPDR S&P Biotech ETF (XBI) increased 11.3% and the ALPS [.

Biotech ETFs Are Making a Comeback

Day One Biopharmaceuticals

Kezar Life Sciences Inc

Lyell Immunopharma

Mirati Therapeutics

Repare Therapeutics

Virtus LifeSci Biotech Clinical Trials ETF (BBC) topped the list of the best-performing U.S. equity ETFs in June, gaining about 10%. The rally was driven by traders' "short squeeze" and investors' bargain hunting.

Biotech ETF Tops in June: 5 Stocks That Outperform

Volt Crypto Industry Revolution and Tech ETF

Global X Lithium & Battery Tech ETF

June has proved to be a brutal month for the stock market. The combination of factors such as decades-high inflation, the Russia-Ukraine conflict and Fed?

4 Sector ETFs That Survived Market Turmoil in June

ARK Innovation ETF

ARK Web x.0 ETF

Renaissance IPO ETF

WisdomTree Cloud Computing Fund

The S&P 500 advanced more than 3% on Friday, logging back-to-back days of gains and marking its first weekly advance since late May.

ETFs Winners of S&P 500's Second Best Week in 2022

Biotechnology sector-related exchange traded funds were in a bright spot on Friday after Bristol Myers Squibb Co. (NYSE: BMY) said it will acquire drug developers Turning Point Therapeutics (NasdaqGS: TPTX). Among the best performing non-leveraged ETFs of Friday, the SPDR S&P Biotech ETF (NYSEArca: XBI) increased 3.1% and the Virtus LifeSci Biotech Clinical Trials ETF [.

Biotech ETFs Strengthen as Bristol Myers Squibb Buys Turning Point

Biotechnology stocks and the related exchange traded funds are under pressure as growth stocks stumble this year, but interested investors have some potential positive facts to ponder. First, biotech valuations are at depressed, rarely seen levels.

Size Up SBIO as Biotech Catalysts Emerge

Since last year, biotechnology stocks and exchange traded funds have been among the most disappointing equity assets, wilting against the backdrop of the coronavirus pandemic and in advance of broader deterioration by growth stocks. Over the past year-plus, it's been common for market observers to ponder exactly when this biotech bear market — which is [.

Betting on Biotech Bear Market Expiration Date

Biotechnology stocks and exchange traded funds have frustrated investors for over a year now, but some analysts and experts believe that this gloomy trend will end soon. Investors willing to take that bet have an array of ETFs to evaluate.

Positioning for Biotech Bounceback

News for Virtus LifeSci Biotech Clinical Trials ETF ETF (BBC)